Dr Reddys Laboratories Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹7,546.40 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 13.79 per cent from ₹8,753.40 crore. This corresponds to a year-on-year *(YoY) decline of 11.51 per cent.
Operating Profit
Operating Profit stands at ₹640.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 66.57 per cent from ₹1,914.50 crore. This corresponds to a year-on-year *(YoY) decline of 69.15 per cent.
PBDT
PBDT stands at ₹756.80 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 63.34 per cent from ₹2,064.20 crore. This corresponds to a year-on-year *(YoY) decline of 69.23 per cent.
Profit Before Tax
Profit Before Tax stands at ₹199.70 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 87.06 per cent from ₹1,543.20 crore. This corresponds to a year-on-year *(YoY) decline of 90.04 per cent.
Net Profit
Net Profit stands at ₹221.30 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 81.40 per cent from ₹1,189.60 crore. This represents a 86.05 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Dr Reddys Laboratories Ltd News
Dr Reddys Laboratories Ltd Earnings
- YOY
- QOQ
Dr Reddys Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Dr Reddys Laboratories Ltd Research Reports
Dr Reddys Laboratories Ltd Financial Reports
Dr Reddys Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Dr Reddy's Labs | -1.22% | -2.19% | 1.16% | 0.64% | 3.41% | 4.31% |
| Divi's Lab. | -2.02% | -1.47% | 0.63% | 4.01% | 3.71% | 1.86% |
| Torrent Pharma. | -3.23% | -3.89% | 3.34% | 0.53% | 17.62% | 40.35% |
| Cipla | -1.39% | -1.06% | 4.77% | 3.45% | -8.22% | -4.85% |
| Zydus Lifesci. | -0.76% | 0.43% | 19.53% | 18.84% | 15.09% | 16.01% |
| Lupin | -0.19% | -0.68% | -3.34% | -1.69% | 8.92% | 15.95% |
| Mankind Pharma | -1.78% | -3.22% | 5.18% | 5.92% | 6.63% | -1.50% |
Company Info
Company Information
Co-Chairman & Managing Director : G V Prasad
Executive Chairman : K Satish Reddy
Independent Director : Shikha Sanjaya Sharma
Independent Director : Leo Puri
Independent Director : K P Krishnan
Independent Director : Pennv Wan
Company Sec. & Compli. Officer : K Randhir Singh
Independent Director : Arun M. Kumar
Independent Director : Claudio Albrecht
Independent Director : Sanjiv Mehta
Independent Director : Alpna Seth